153 related articles for article (PubMed ID: 3011243)
1. Antibody-Pseudomonas exotoxin A conjugates cytotoxic to human breast cancer cells in vitro.
Bjorn MJ; Groetsema G; Scalapino L
Cancer Res; 1986 Jul; 46(7):3262-7. PubMed ID: 3011243
[TBL] [Abstract][Full Text] [Related]
2. Characterization of immunotoxins active against ovarian cancer cell lines.
Pirker R; FitzGerald DJ; Hamilton TC; Ozols RF; Laird W; Frankel AE; Willingham MC; Pastan I
J Clin Invest; 1985 Sep; 76(3):1261-7. PubMed ID: 3930572
[TBL] [Abstract][Full Text] [Related]
3. Immunotoxins made with a recombinant form of Pseudomonas exotoxin A that do not require proteolysis for activity.
Theuer CP; Kreitman RJ; FitzGerald DJ; Pastan I
Cancer Res; 1993 Jan; 53(2):340-7. PubMed ID: 8417828
[TBL] [Abstract][Full Text] [Related]
4. Anti-tumor activities of immunotoxins made of monoclonal antibody B3 and various forms of Pseudomonas exotoxin.
Pai LH; Batra JK; FitzGerald DJ; Willingham MC; Pastan I
Proc Natl Acad Sci U S A; 1991 Apr; 88(8):3358-62. PubMed ID: 2014255
[TBL] [Abstract][Full Text] [Related]
5. Immunotoxins of Pseudomonas exotoxin A (PE): effect of linkage on conjugate yield, potency, selectivity and toxicity.
Morgan AC; Sivam G; Beaumier P; McIntyre R; Bjorn M; Abrams PG
Mol Immunol; 1990 Mar; 27(3):273-82. PubMed ID: 2342490
[TBL] [Abstract][Full Text] [Related]
6. Therapy of human cervical carcinoma with monoclonal antibody-Pseudomonas exotoxin conjugates.
Roffler SR; Yu MH; Chen BM; Tung E; Yeh MY
Cancer Res; 1991 Aug; 51(15):4001-7. PubMed ID: 1855216
[TBL] [Abstract][Full Text] [Related]
7. Antitumor effects of B3-PE and B3-LysPE40 in a nude mouse model of human breast cancer and the evaluation of B3-PE toxicity in monkeys.
Pai LH; Batra JK; FitzGerald DJ; Willingham MC; Pastan I
Cancer Res; 1992 Jun; 52(11):3189-93. PubMed ID: 1591729
[TBL] [Abstract][Full Text] [Related]
8. An epidermal growth factor-ricin A chain (EGF-RTA)-resistant mutant and an epidermal growth factor-Pseudomonas endotoxin (EGF-PE)-resistant mutant have distinct phenotypes.
Banker DE; Pastan I; Gottesman MM; Herschman HR
J Cell Physiol; 1989 Apr; 139(1):51-7. PubMed ID: 2496133
[TBL] [Abstract][Full Text] [Related]
9. Immunotoxins containing Pseudomonas exotoxin that target LeY damage human endothelial cells in an antibody-specific mode: relevance to vascular leak syndrome.
Kuan CT; Pai LH; Pastan I
Clin Cancer Res; 1995 Dec; 1(12):1589-94. PubMed ID: 9815960
[TBL] [Abstract][Full Text] [Related]
10. Systemic immunotoxin treatment inhibits formation of human breast cancer metastasis and tumor growth in nude rats.
Engebraaten O; Sivam G; Juell S; Fodstad O
Int J Cancer; 2000 Dec; 88(6):970-6. PubMed ID: 11093823
[TBL] [Abstract][Full Text] [Related]
11. Monovalent immunotoxin containing truncated form of Pseudomonas exotoxin as potent antitumor agent.
Debinski W; Pastan I
Cancer Res; 1992 Oct; 52(19):5379-85. PubMed ID: 1394141
[TBL] [Abstract][Full Text] [Related]
12. Generation of a potent chimeric toxin by replacement of domain III of Pseudomonas exotoxin with ricin A chain KDEL.
Pitcher C; Roberts L; Fawell S; Zdanovsky AG; FitzGerald DJ; Lord JM
Bioconjug Chem; 1995; 6(5):624-9. PubMed ID: 8974463
[TBL] [Abstract][Full Text] [Related]
13. Immunotoxins directed against the high-molecular-weight melanoma-associated antigen. Identification of potent antibody-toxin combinations.
Godal A; Kumle B; Pihl A; Juell S; Fodstad O
Int J Cancer; 1992 Oct; 52(4):631-5. PubMed ID: 1399146
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo cytotoxic activities of recombinant immunotoxin 8H9(Fv)-PE38 against breast cancer, osteosarcoma, and neuroblastoma.
Onda M; Wang QC; Guo HF; Cheung NK; Pastan I
Cancer Res; 2004 Feb; 64(4):1419-24. PubMed ID: 14973056
[TBL] [Abstract][Full Text] [Related]
15. Enhanced therapeutic efficacy against an ovarian tumor xenograft of immunotoxins used in conjunction with recombinant alpha-interferon.
Pearson JW; Hedrick E; Fogler WE; Bull RL; Ferris DK; Riggs CW; Wiltrout RH; Sivam G; Morgan AC; Groves E
Cancer Res; 1990 Oct; 50(19):6379-88. PubMed ID: 2144790
[TBL] [Abstract][Full Text] [Related]
16. Characterization of monoclonal antibody B7, which neutralizes the cytotoxicity of Pseudomonas aeruginosa exotoxin A.
Shang HF; Yeh ML; Lin CP; Hwang J
Clin Diagn Lab Immunol; 1996 Nov; 3(6):727-32. PubMed ID: 8914766
[TBL] [Abstract][Full Text] [Related]
17. Immunotoxins recognising a new epitope on the neural cell adhesion molecule have potent cytotoxic effects against small cell lung cancer.
Zangemeister-Wittke U; Collinson AR; Frösch B; Waibel R; Schenker T; Stahel RA
Br J Cancer; 1994 Jan; 69(1):32-9. PubMed ID: 7506925
[TBL] [Abstract][Full Text] [Related]
18. B3(Fab)-PE38M: a recombinant immunotoxin in which a mutant form of Pseudomonas exotoxin is fused to the Fab fragment of monoclonal antibody B3.
Choe M; Webber KO; Pastan I
Cancer Res; 1994 Jul; 54(13):3460-7. PubMed ID: 8012967
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of the activity of immunotoxins made with either ricin A chain or Pseudomonas exotoxin in human ovarian and epidermoid carcinoma cell lines.
Pirker R; FitzGerald DJ; Willingham MC; Pastan I
Cancer Res; 1988 Jul; 48(14):3919-23. PubMed ID: 3260128
[TBL] [Abstract][Full Text] [Related]
20. Anti-prostate immunotoxins: cytotoxicity of E4 antibody-Pseudomonas exotoxin constructs.
Essand M; Pastan I
Int J Cancer; 1998 Jul; 77(1):123-7. PubMed ID: 9639403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
